As on Tuesday, NRX Pharmaceuticals Inc (NASDAQ: NRXP) got off with the flyer as it spiked 43.79% to $2.20, before settling in for the price of $1.53 at the close. Taking a more long-term approach, NRXP posted a 52-week range of $1.10-$7.33.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 53.58%. This publicly-traded company’s shares outstanding now amounts to $11.37 million, simultaneously with a float of $9.20 million. The organization now has a market capitalization sitting at $38.26 million. At the time of writing, stock’s 50-day Moving Average stood at $1.3300, while the 200-day Moving Average is $2.4200.
NRX Pharmaceuticals Inc (NRXP) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. NRX Pharmaceuticals Inc’s current insider ownership accounts for 23.89%, in contrast to 5.91% institutional ownership. According to the most recent insider trade that took place on Dec 17 ’24, this organization’s Chairman and Chief Scientist bought 40,000 shares at the rate of 1.17, making the entire transaction reach 46,800 in total value, affecting insider ownership by 84,634.
NRX Pharmaceuticals Inc (NRXP) Earnings and Revenue Records
NRX Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 53.58% and is forecasted to reach 0.32 in the upcoming year.
NRX Pharmaceuticals Inc (NASDAQ: NRXP) Trading Performance Indicators
Let’s observe the current performance indicators for NRX Pharmaceuticals Inc (NRXP). It’s Quick Ratio in the last reported quarter now stands at 0.20. The Stock has managed to achieve an average true range (ATR) of 0.23.
In the same vein, NRXP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.15, a figure that is expected to reach -0.32 in the next quarter, and analysts are predicting that it will be 0.32 at the market close of one year from today.
Technical Analysis of NRX Pharmaceuticals Inc (NRXP)
Through scrutinizing the latest numbers posted by the [NRX Pharmaceuticals Inc, NRXP], it can be observed that its last 5-days Average volume of 3.44 million was better the volume of 0.27 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 51.54% While, its Average True Range was 0.2900.
Raw Stochastic average of NRX Pharmaceuticals Inc (NRXP) in the period of the previous 100 days is set at 74.32%, which indicates a major rise in contrast to 73.43% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 198.24% that was higher than 99.42% volatility it exhibited in the past 100-days period.
